查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1614302

女性骨盆腔植入市场：按产品类型、适应症和最终用户划分 - 全球预测 2025-2030

Female Pelvic Implants Market by Product Type (Vaginal Graft Implants, Vaginal Mesh Implants, Vaginal Sling), Indication (Pelvic Organ Prolapse, Stress Urinary Incontinence), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年女性骨盆腔植入市场价值为9.7232亿美元，预计到2024年将达到10.1559亿美元，复合年增长率为4.76%，到2030年将达到13.4729亿美元。

女性骨盆腔植入市场是更广泛的医疗设备业中的一个专业领域，专注于旨在解决骨盆器官脱垂(POP) 和压力性尿失禁 (SUI) 等疾病的产品。由于老化、肥胖和分娩影响等因素导致这些疾病越来越普遍，因此这些植入非常重要。应用主要是支持脆弱骨盆底结构的外科手术，最终用户包括医院、妇科诊所和专科手术中心。市场成长是由材料科学的技术进步所推动的，这些技术进步提高了植入的生物相容性和使用寿命，以及患者对手术选择的认识和接受度的提高。医疗保健支出的增加和政府的支持措施也对市场扩张做出了积极贡献。

主要市场统计
基准年[2023] 97232万美元
预测年份 [2024] 1,015,590,000 美元
预测年份 [2030] 1,347.29 百万美元
复合年增长率（%） 4.76%

然而，市场面临严格的监管标准和植入后併发症等挑战，这对製造商和消费者来说都是阻碍力。有关产品缺陷的负面宣传和诉讼可能会削弱消费者的信心，导致市场审查更加严格。儘管有这些挑战，但仍有机会瞄准医疗需求未被满足的新兴国家，并推动微创手术技术以改善病患的治疗效果。创新的主要领域是开发下一代植入，这些植入物利用先进的生物材料和智慧技术来实现即时监控和调整。研究应着重于提高现有产品的安全性，并开拓新的解决方案，以缩短恢復时间并提高长期疗效。

就市场特征而言，竞争格局是由持续的研发驱动的，要求企业与医疗保健提供者建立强有力的合作，并投资教育倡议以增强市场信心。公司可以透过优先考虑以患者为中心的设计和强大的上市后监测系统来追踪产品性能和患者满意度，从而利用成长。因此，我们专注于与研究机构合作并进入临床试验，使我们在这个动态的市场环境中占据优势。

市场动态：揭示快速发展的女性骨盆植入市场的关键市场洞察

供需的动态交互作用正在改变女性骨盆腔植入市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 女性骨盆腔疾病增加，人们对女性生殖和全身健康的认识不断提高
    • 政府努力扩大妇女获得保健和医疗服务的机会
  • 市场限制因素
    • 应对监管环境的困难和诉讼的出现
  • 市场机会
    • 安全、高性能、功能性女性骨盆腔植入的开发不断取得进展
    • 扩大手术中心和生育诊所的范围
  • 市场挑战
    • 缺乏训练有素的外科医生和绩效问题

波特五力：开拓女性骨盆腔植入市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解女性骨盆腔植入市场的外部影响

外部宏观环境因素在塑造女性骨盆腔植入市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解女性骨盆腔植入市场的竞争状况

对女性骨盆腔植入市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵女性骨盆植入市场供应商的绩效评估

FPNV 定位矩阵是评估女性骨盆植入市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，规划女性骨盆腔植入市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对女性骨盆植入市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 女性骨盆腔疾病的发生率不断上升，人们对女性生殖健康和整体健康的认识不断提高
      • 政府努力扩大妇女获得保健和医疗服务的机会
    • 抑制因素
      • 监理条件应对困难、诉讼发生
    • 机会
      • 女性骨盆腔植入的开发不断取得进展，安全性、性能和功能均提高
      • 在世界各地扩大手术中心和生育诊所
    • 任务
      • 缺乏训练有素的外科医生和绩效问题
  • 市场区隔分析
    • 产品类型：由于有效治疗应力性尿失禁，阴道吊带的使用范围扩大
    • 最终用户：医院的综合设施和广泛的专家正在增加女性骨盆植入的采用。
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章女性骨盆腔植入市场：依产品类型

  • 阴道植入
  • 阴道网状植入
  • 阴道吊带

第七章依适应症分類的女性骨盆腔植入市场

  • 骨盆器官脱垂
  • 应力性尿失禁

第八章女性骨盆植入市场：依最终用户分类

  • 门诊手术中心
  • 医院
  • 专科诊所

第九章美洲女性骨盆腔植入市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太地区女性骨盆腔植入市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲女性骨盆腔植入市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Caldera Medical 与 Premier 签署女性医疗护理和手术失禁特别合同
    • CurvaFix 融资 3,900 万美元，用于增强治疗骨盆骨折的弯曲手术设备
    • FemTherapeutics 筹集 180 万美元，透过患者专用妇科义肢促进女性健康
  • 战略分析和建议

公司名单

  • Advin Urology
  • B. Braun of America Inc.
  • Betatech Medical
  • Boston Scientific Corporation
  • Caldera Medical
  • CARDIOLINK SL by CB Scientific, Inc.
  • Coloplast Corp.
  • Cook Group Incorporated
  • CurvaFix, Inc.
  • Medtronic
  • Narang Medical Limited
  • Neomedic Int
  • Olympus Corporation
  • PALEX MEDICAL, SA
  • pfm Medical GmbH
  • PROMEDON GmbH
  • SARS Cousin Biotech
  • Tecomet, Inc.
  • Zimmer Biomet
  • ZSI Surgical Implants SRL
Product Code: MRR-9E71DF483B9B

The Female Pelvic Implants Market was valued at USD 972.32 million in 2023, expected to reach USD 1,015.59 million in 2024, and is projected to grow at a CAGR of 4.76%, to USD 1,347.29 million by 2030.

The market for female pelvic implants is a specialized segment within the broader medical devices industry, focusing on products designed to address conditions like pelvic organ prolapse (POP) and stress urinary incontinence (SUI). These implants are crucial due to the increasing prevalence of these conditions, often attributed to factors such as aging populations, obesity, and childbirth effects. Applications primarily involve surgical procedures to provide support to weakened pelvic floor structures, with end-users including hospitals, gynecological clinics, and specialized surgical centers. Market growth is propelled by technological advancements in material sciences, improving implant biocompatibility and longevity, alongside increasing awareness and acceptance of surgical options among patients. Rising healthcare expenditure, coupled with supportive government initiatives, also contributes positively to market expansion.

KEY MARKET STATISTICS
Base Year [2023] USD 972.32 million
Estimated Year [2024] USD 1,015.59 million
Forecast Year [2030] USD 1,347.29 million
CAGR (%) 4.76%

However, the market faces challenges such as stringent regulatory standards and post-implant complications, which can deter both manufacturers and consumers. Negative media coverage and litigation related to product failures have sometimes undermined consumer confidence, intensifying market scrutiny. Despite these challenges, opportunities exist in targeting emerging economies with unmet medical needs and advancing minimally invasive surgical techniques that offer better patient outcomes. A key area for innovation lies in developing next-generation implants utilizing advanced biomaterials and smart technology capable of real-time monitoring and adjustments. Research should focus on both improving the safety profile of existing products and pioneering new solutions that reduce recovery times and enhance long-term efficacy.

In terms of market nature, female pelvic implants remain a competitive landscape driven by continuous R&D, requiring companies to foster strong collaborative ties with healthcare providers and invest in educational initiatives to reinforce market trust. Companies can capitalize on growth by prioritizing patient-centric designs and robust post-market surveillance systems to track product performance and patient satisfaction. Consequently, focusing on partnerships with research institutions and participating in clinical trials can provide an edge in this dynamic market environment.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Female Pelvic Implants Market

The Female Pelvic Implants Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing incidences of pelvic disorders among women and awareness about women's reproductive and overall health
    • Government initiatives to expand access to healthcare and medical services for women
  • Market Restraints
    • Difficulties in navigating the regulatory landscape and incidences of lawsuits
  • Market Opportunities
    • Ongoing advancements in developing female pelvic implants with better safety, performance, and functional features
    • Expansion of surgical centers and fertility clinics across the world
  • Market Challenges
    • Shortage of adequately trained surgeons and performance issues

Porter's Five Forces: A Strategic Tool for Navigating the Female Pelvic Implants Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Female Pelvic Implants Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Female Pelvic Implants Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Female Pelvic Implants Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Female Pelvic Implants Market

A detailed market share analysis in the Female Pelvic Implants Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Female Pelvic Implants Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Female Pelvic Implants Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Female Pelvic Implants Market

A strategic analysis of the Female Pelvic Implants Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Female Pelvic Implants Market, highlighting leading vendors and their innovative profiles. These include Advin Urology, B. Braun of America Inc., Betatech Medical, Boston Scientific Corporation, Caldera Medical, CARDIOLINK S.L. by CB Scientific, Inc., Coloplast Corp., Cook Group Incorporated, CurvaFix, Inc., Medtronic, Narang Medical Limited, Neomedic Int, Olympus Corporation, PALEX MEDICAL, S.A, pfm Medical GmbH, PROMEDON GmbH, SARS Cousin Biotech, Tecomet, Inc., Zimmer Biomet, and ZSI Surgical Implants S.R.L..

Market Segmentation & Coverage

This research report categorizes the Female Pelvic Implants Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Vaginal Graft Implants, Vaginal Mesh Implants, and Vaginal Sling.
  • Based on Indication, market is studied across Pelvic Organ Prolapse and Stress Urinary Incontinence.
  • Based on End User, market is studied across Ambulatory Surgical Centers, Hospitals, and Specialty Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidences of pelvic disorders among women and awareness about women's reproductive and overall health
      • 5.1.1.2. Government initiatives to expand access to healthcare and medical services for women
    • 5.1.2. Restraints
      • 5.1.2.1. Difficulties in navigating the regulatory landscape and incidences of lawsuits
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing advancements in developing female pelvic implants with better safety, performance, and functional features
      • 5.1.3.2. Expansion of surgical centers and fertility clinics across the world
    • 5.1.4. Challenges
      • 5.1.4.1. Shortage of adequately trained surgeons and performance issues
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product Type: Expanding usage of vaginal sling due to its efficacy in treating stress urinary incontinence
    • 5.2.2. End User: Emerging adoption of female pelvic implants by hospitals owing to their comprehensive facilities and wide range of specialists
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Female Pelvic Implants Market, by Product Type

  • 6.1. Introduction
  • 6.2. Vaginal Graft Implants
  • 6.3. Vaginal Mesh Implants
  • 6.4. Vaginal Sling

7. Female Pelvic Implants Market, by Indication

  • 7.1. Introduction
  • 7.2. Pelvic Organ Prolapse
  • 7.3. Stress Urinary Incontinence

8. Female Pelvic Implants Market, by End User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Hospitals
  • 8.4. Specialty Clinics

9. Americas Female Pelvic Implants Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Female Pelvic Implants Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Female Pelvic Implants Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Caldera Medical awarded Specialty Women's Health and Surgical Incontinence contract Agreement with Premier Inc
    • 12.3.2. CurvaFix lands USD 39 million to boost curved surgical device used for pelvic fracture treatment
    • 12.3.3. FemTherapeutics Raises USD 1.8 Million To Advance Women's Health With Its Patient-Specific Gynecological Prosthetics
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Advin Urology
  • 2. B. Braun of America Inc.
  • 3. Betatech Medical
  • 4. Boston Scientific Corporation
  • 5. Caldera Medical
  • 6. CARDIOLINK S.L. by CB Scientific, Inc.
  • 7. Coloplast Corp.
  • 8. Cook Group Incorporated
  • 9. CurvaFix, Inc.
  • 10. Medtronic
  • 11. Narang Medical Limited
  • 12. Neomedic Int
  • 13. Olympus Corporation
  • 14. PALEX MEDICAL, S.A
  • 15. pfm Medical GmbH
  • 16. PROMEDON GmbH
  • 17. SARS Cousin Biotech
  • 18. Tecomet, Inc.
  • 19. Zimmer Biomet
  • 20. ZSI Surgical Implants S.R.L.

LIST OF FIGURES

  • FIGURE 1. FEMALE PELVIC IMPLANTS MARKET RESEARCH PROCESS
  • FIGURE 2. FEMALE PELVIC IMPLANTS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS FEMALE PELVIC IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS FEMALE PELVIC IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES FEMALE PELVIC IMPLANTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES FEMALE PELVIC IMPLANTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC FEMALE PELVIC IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC FEMALE PELVIC IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA FEMALE PELVIC IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA FEMALE PELVIC IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. FEMALE PELVIC IMPLANTS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. FEMALE PELVIC IMPLANTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. FEMALE PELVIC IMPLANTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. FEMALE PELVIC IMPLANTS MARKET DYNAMICS
  • TABLE 7. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY VAGINAL GRAFT IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY VAGINAL MESH IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY VAGINAL SLING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY PELVIC ORGAN PROLAPSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY STRESS URINARY INCONTINENCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL FEMALE PELVIC IMPLANTS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS FEMALE PELVIC IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES FEMALE PELVIC IMPLANTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC FEMALE PELVIC IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA FEMALE PELVIC IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM FEMALE PELVIC IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM FEMALE PELVIC IMPLANTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM FEMALE PELVIC IMPLANTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 145. FEMALE PELVIC IMPLANTS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 146. FEMALE PELVIC IMPLANTS MARKET, FPNV POSITIONING MATRIX, 2023